New York-based venture capital firm Dimension Capital is setting its sights on raising as much as $750 million for its third investment fund, according to newly filed regulatory documents.
The move signals the firm’s continued push to expand its footprint in deep technology and science-driven startups.
SEC Filing Reveals Early Stage of Fundraising
A filing submitted to the U.S. Securities and Exchange Commission indicates that the planned vehicle, Dimension Capital III, L.P., has not yet secured any committed capital.
While the fund is formally registered and open for fundraising, no investments have been reported at this stage.
The disclosure reflects an early step in the fundraising process, which typically unfolds over several months as institutional investors assess strategy, track record, and market conditions before committing capital.
Leadership Behind the New Fund
The filing identifies Adam Goulburn as the individual associated with the fundraising effort. Goulburn is part of the leadership team guiding Dimension Capital’s investment strategy.
Alongside co-founder Zavain Dar, Goulburn helps steer the firm’s direction across its multi-stage investment approach, which focuses on identifying companies operating at the intersection of science, engineering, and advanced computing.
A Research-Driven Investment Strategy
Dimension Capital has built its reputation as a research-oriented venture firm that backs companies working on frontier technologies.
Its investment thesis spans areas where scientific discovery meets scalable computing power, often targeting early-stage startups with long-term technological ambitions.
The firm’s approach emphasizes close collaboration with founders, positioning itself as a partner in developing complex innovations rather than a traditional passive investor.
What the New Fund Signals for the Firm
If successfully raised at its targeted size, Dimension Capital III would provide the firm with significant new capital to deploy across emerging sectors.
The fund would also reinforce the firm’s commitment to backing high-risk, high-reward scientific and computational breakthroughs.
For now, however, the fundraising remains in its initial phase, with no capital yet secured and investor participation still unfolding.
